A rare case of Wilkie's syndrome with infantile hypertrophic pyloric stenosis. [PDF]
Stamov P, Stamova S.
europepmc +1 more source
The impact and management of hyperemesis gravidarum: Current and future perspectives
Abstract Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting in pregnancy affecting around 1%–3% of pregnancies worldwide and is the most common reason for hospital admission in early pregnancy. HG can have lasting consequences for both pregnant individuals and their offspring.
L. M. van der Minnen+4 more
wiley +1 more source
An application of deep learning model InceptionTime to predict nausea, vomiting, diarrhoea, and constipation using the gastro-intestinal pacemaker activity drug database (GIPADD). [PDF]
Chau HC, Liu JYH, Rudd JA.
europepmc +1 more source
Abstract Background Gynecological surgery is generally associated with a high risk of postoperative nausea and vomiting (PONV), for which a combination of antiemetic therapies is advised, but adherence to these protocols is often low. Given the current reality, a preferred 5‐HT3 receptor antagonist for preventing PONV as a result of gynecological ...
Hongxia Xu+7 more
wiley +1 more source
Benign Vomiting-Induced Hepatic Portal Venous Gas: A Case Report. [PDF]
Yeo Z, Dor R.
europepmc +1 more source
Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer
Abstract Objective To compare overall survival (OS) in patients with high‐grade serous ovarian cancer (HGSOC) treated with intraperitoneal (IP) chemotherapy versus intravenous (IV) chemotherapy. Methods A retrospective study of Stage III HGSOC with optimal primary cytoreduction during 2007–2019, followed by adjuvant IP or IV chemotherapy.
Joshua S Cheruvathur+7 more
wiley +1 more source
The effect of peppermint essential oil on postoperative nausea, vomiting, and pain in rhinoplasty patients: a randomized clinical trial. [PDF]
Parvizi A+5 more
europepmc +1 more source
Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy-the DANGER-emesis study. [PDF]
Detlefsen SS+8 more
europepmc +1 more source